Knowing how many people are vaccinated against an existing or re-emerging threat is a key factor guiding public health decisions, but such information is often sparse or non-existent in many regions, ...

Many vaccines must be kept at low temperatures to remain effective. This makes transportation expensive and difficult, ...

In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant ...

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...

Key opportunities in the animal vaccines market include addressing livestock disease outbreaks, leveraging next-gen mRNA ...

For children — and many adults — the fear of injections remains a major barrier to vaccination. But research led by Elodie Segura, PhD, from the Immunity and Cancer Laboratory at the Institut Curie in ...

The recombinant zoster vaccine (Shingrix) is very effective against the viral rash, but research has found that it may also ...

New real-world evidence is helping address a major safety gap around hepatitis E vaccine use in pregnancy, a population at ...